Analyte measured to Lymecycline bio­equi­va­lence study [Bioanalytics]

posted by Dr_Dan  – Germany, 2013-09-04 22:05 (4284 d 15:30 ago) – Posting: # 11439
Views: 7,252

Dear Manoj Singh
As Mauricio pointed out above the Public Assessment Report from MHRA (UK/H/1889/002/DC) states that the pharmacokinetics were based on Tetracycline and not Lymecycline as a consequence that Lymecycline is a prodrug which is not available in the systemic circulation.
Kind regards
Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,673 registered users;
76 visitors (0 registered, 76 guests [including 17 identified bots]).
Forum time: 13:36 CEST (Europe/Vienna)

It’s difficult to work in a group
when you are omnipotent.    John de Lancie (as Q)

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5